BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21551983)

  • 21. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
    Kuint J; Barzilai A; Regev-Yochay G; Rubinstein E; Keller N; Maayan-Metzger A
    Eur J Pediatr; 2007 Apr; 166(4):319-25. PubMed ID: 17051356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
    Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
    Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
    J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea.
    Park SH; Park C; Yoo JH; Choi SM; Choi JH; Shin HH; Lee DG; Lee S; Kim J; Choi SE; Kwon YM; Shin WS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):146-55. PubMed ID: 19128184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis.
    Goudarzi M; Seyedjavadi SS; Nasiri MJ; Goudarzi H; Sajadi Nia R; Dabiri H
    Microb Pathog; 2017 Mar; 104():328-335. PubMed ID: 28159661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
    Ho KM; Robinson JO
    Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiological and molecular characteristics of hospital-acquired methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University Adult Hospital in 2004-2005].
    Akoğlu H; Zarakolu P; Altun B; Ünal S
    Mikrobiyol Bul; 2010 Jul; 44(3):343-55. PubMed ID: 21063984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
    Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
    Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
    Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia.
    Sit PS; Teh CS; Idris N; Sam IC; Syed Omar SF; Sulaiman H; Thong KL; Kamarulzaman A; Ponnampalavanar S
    BMC Infect Dis; 2017 Apr; 17(1):274. PubMed ID: 28407796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004.
    Takata T; Miyazaki M; Li H; Healy M; Frye S; Tanaka K; Hara S; Kamimura H; Yoshimura H; Matsunaga A; Ohta D; Ishikura H; Tamura K; Tang YW
    J Infect Chemother; 2012 Apr; 18(2):199-206. PubMed ID: 22009526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
    Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Shurland S; Zhan M; Bradham DD; Roghmann MC
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Martín-Gandul C; López-Medrano F; de Gopegui ER; Ramón Blanco J; García-Pardo G; Calbo E; Horcajada JP; Granados A; Jover-Sáenz A; Dueñas C; Pujol M;
    Clin Microbiol Infect; 2014 Apr; 20(4):361-7. PubMed ID: 23991832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.